Publicação
Erythematosus systemic lupus in Portugal: adherence and approach to medication therapy
| Resumo: | Erythematosus Systemic Lupus is a chronic inflammatory disease that affects about half a million Europeans, more frequent in the southern countries and fertile women. The therapy adherence in this disease is not well known, particularly in Portugal. Objectives: To characterize the medication therapy of Lupus, estimate the prevalence of therapy adherence and associated factors in Portugal. Methods: This exploratory, cross-sectional and correlational study was based on a questionnaire, with MAT scale (measure of adherence to therapy) validated for the Portuguese population (Delgado & Lima, 2001), applied to 276 members of Patients with Lupus Association, in Portugal. It was used descriptive statistics and Chi-Square test, with a significance level of 5%. Results: The sample consisted mostly of females (96.0%), with an average age of 41 (± 11.46) years old. Antimalarials, antiinflammatory and immunosuppressive drugs are the pharmacotherapeutic groups more used. The prevalence of therapy adherence was 80.2%. Factors associated with Lupus therapy nonadherence are side effects, do not feel improvement, not acceptance, disease in remission and do not feel the need to treat (p<0.05). Conclusions: This study shows a considerable prevalence of Lupus therapy adherence, being several factors associated with nonadherence. It is important the intervention of health professionals to improve therapy adherence for disease control. |
|---|---|
| Autores principais: | Pinto, Isabel C. |
| Outros Autores: | Nascimento, Luís; Faria, Ângela; Lopes, Márcia; Afonso, Sílvia |
| Assunto: | Erythematosus systemic lupus Therapy adherence |
| Ano: | 2016 |
| País: | Portugal |
| Tipo de documento: | documento de conferência |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Instituto Politécnico de Bragança |
| Idioma: | inglês |
| Origem: | Biblioteca Digital do IPB |
| _version_ | 1863851434811850752 |
|---|---|
| author | Pinto, Isabel C. |
| author2 | Nascimento, Luís Faria, Ângela Lopes, Márcia Afonso, Sílvia |
| author2_role | author author author author |
| author_facet | Pinto, Isabel C. Nascimento, Luís Faria, Ângela Lopes, Márcia Afonso, Sílvia |
| author_role | author |
| contributor_name_str_mv | Biblioteca Digital do IPB |
| country_str | PT |
| creators_json_str | [{\"Person.name\":\"Pinto, Isabel C.\",\"Person.identifier.orcid\":\"0000-0003-4745-6489\"},{\"Person.name\":\"Nascimento, Luís\",\"Person.identifier.orcid\":\"0000-0002-1302-2570\"},{\"Person.name\":\"Faria, Ângela\"},{\"Person.name\":\"Lopes, Márcia\"},{\"Person.name\":\"Afonso, Sílvia\"}] |
| datacite.contributors.contributor.contributorName.fl_str_mv | Biblioteca Digital do IPB |
| datacite.creators.creator.creatorName.fl_str_mv | Pinto, Isabel C. Nascimento, Luís Faria, Ângela Lopes, Márcia Afonso, Sílvia |
| datacite.date.Accepted.fl_str_mv | 2016-01-01T00:00:00Z |
| datacite.date.available.fl_str_mv | 2018-03-14T17:07:15Z |
| datacite.date.embargoed.fl_str_mv | 2018-03-14T17:07:15Z |
| datacite.rights.fl_str_mv | http://purl.org/coar/access_right/c_abf2 |
| datacite.subjects.subject.fl_str_mv | Erythematosus systemic lupus Therapy adherence |
| datacite.titles.title.fl_str_mv | Erythematosus systemic lupus in Portugal: adherence and approach to medication therapy |
| dc.contributor.none.fl_str_mv | Biblioteca Digital do IPB |
| dc.creator.none.fl_str_mv | Pinto, Isabel C. Nascimento, Luís Faria, Ângela Lopes, Márcia Afonso, Sílvia |
| dc.date.Accepted.fl_str_mv | 2016-01-01T00:00:00Z |
| dc.date.available.fl_str_mv | 2018-03-14T17:07:15Z |
| dc.date.embargoed.fl_str_mv | 2018-03-14T17:07:15Z |
| dc.format.none.fl_str_mv | application/pdf |
| dc.identifier.none.fl_str_mv | http://hdl.handle.net/10198/16300 |
| dc.language.none.fl_str_mv | eng |
| dc.publisher.none.fl_str_mv | Elsevier |
| dc.rights.cclincense.fl_str_mv | http://creativecommons.org/licenses/by/4.0/ |
| dc.rights.none.fl_str_mv | http://purl.org/coar/access_right/c_abf2 |
| dc.subject.none.fl_str_mv | Erythematosus systemic lupus Therapy adherence |
| dc.title.fl_str_mv | Erythematosus systemic lupus in Portugal: adherence and approach to medication therapy |
| dc.type.none.fl_str_mv | http://purl.org/coar/resource_type/c_c94f |
| description | Erythematosus Systemic Lupus is a chronic inflammatory disease that affects about half a million Europeans, more frequent in the southern countries and fertile women. The therapy adherence in this disease is not well known, particularly in Portugal. Objectives: To characterize the medication therapy of Lupus, estimate the prevalence of therapy adherence and associated factors in Portugal. Methods: This exploratory, cross-sectional and correlational study was based on a questionnaire, with MAT scale (measure of adherence to therapy) validated for the Portuguese population (Delgado & Lima, 2001), applied to 276 members of Patients with Lupus Association, in Portugal. It was used descriptive statistics and Chi-Square test, with a significance level of 5%. Results: The sample consisted mostly of females (96.0%), with an average age of 41 (± 11.46) years old. Antimalarials, antiinflammatory and immunosuppressive drugs are the pharmacotherapeutic groups more used. The prevalence of therapy adherence was 80.2%. Factors associated with Lupus therapy nonadherence are side effects, do not feel improvement, not acceptance, disease in remission and do not feel the need to treat (p<0.05). Conclusions: This study shows a considerable prevalence of Lupus therapy adherence, being several factors associated with nonadherence. It is important the intervention of health professionals to improve therapy adherence for disease control. |
| dirty | 0 |
| eu_rights_str_mv | openAccess |
| format | conferenceObject |
| fulltext.url.fl_str_mv | https://bibliotecadigital.ipb.pt/bitstreams/35f324ff-41cb-4adc-bf46-8ba81fda4492/download |
| id | ipb_7aeef5730cf677cb625fda67b04f50cb |
| identifier.url.fl_str_mv | http://hdl.handle.net/10198/16300 |
| instacron_str | ipb |
| institution | Instituto Politécnico de Bragança |
| instname_str | Instituto Politécnico de Bragança |
| language | eng |
| network_acronym_str | ipb |
| network_name_str | Biblioteca Digital do IPB |
| oai_identifier_str | oai:bibliotecadigital.ipb.pt:10198/16300 |
| organization_str_mv | urn:organizationAcronym:ipb |
| person_str_mv | Pinto, Isabel C. Pinto, Isabel C. https://www.ciencia-id.pt/851B-247F-C650 851B-247F-C650 http://orcid.org/0000-0003-4745-6489 0000-0003-4745-6489 Nascimento, Luís Nascimento, Luís https://www.ciencia-id.pt/9918-ED25-623E 9918-ED25-623E http://orcid.org/0000-0002-1302-2570 0000-0002-1302-2570 Faria, Ângela Lopes, Márcia Afonso, Sílvia |
| publishDate | 2016 |
| publisher.none.fl_str_mv | Elsevier |
| reponame_str | Biblioteca Digital do IPB |
| repository_id_str | urn:repositoryAcronym:ipb |
| service_str_mv | urn:repositoryAcronym:ipb |
| spelling | engElsevierpt_PTErythematosus Systemic Lupus is a chronic inflammatory disease that affects about half a million Europeans, more frequent in the southern countries and fertile women. The therapy adherence in this disease is not well known, particularly in Portugal. Objectives: To characterize the medication therapy of Lupus, estimate the prevalence of therapy adherence and associated factors in Portugal. Methods: This exploratory, cross-sectional and correlational study was based on a questionnaire, with MAT scale (measure of adherence to therapy) validated for the Portuguese population (Delgado & Lima, 2001), applied to 276 members of Patients with Lupus Association, in Portugal. It was used descriptive statistics and Chi-Square test, with a significance level of 5%. Results: The sample consisted mostly of females (96.0%), with an average age of 41 (± 11.46) years old. Antimalarials, antiinflammatory and immunosuppressive drugs are the pharmacotherapeutic groups more used. The prevalence of therapy adherence was 80.2%. Factors associated with Lupus therapy nonadherence are side effects, do not feel improvement, not acceptance, disease in remission and do not feel the need to treat (p<0.05). Conclusions: This study shows a considerable prevalence of Lupus therapy adherence, being several factors associated with nonadherence. It is important the intervention of health professionals to improve therapy adherence for disease control.application/pdfpt_PTErythematosus systemic lupus in Portugal: adherence and approach to medication therapyPersonalPinto, Isabel C.DSpacehttp://dspace.org/items/751d74ab-e27c-4713-97ba-62cad38d1890DSpacehttp://dspace.org/items/751d74ab-e27c-4713-97ba-62cad38d1890PintoIsabel C.Ciência IDhttps://www.ciencia-id.pt851B-247F-C650ORCIDhttp://orcid.org0000-0003-4745-6489PersonalNascimento, LuísDSpacehttp://dspace.org/items/9e7bebc0-4460-4f4c-b687-10e34c3b36b9DSpacehttp://dspace.org/items/9e7bebc0-4460-4f4c-b687-10e34c3b36b9NascimentoLuísCiência IDhttps://www.ciencia-id.pt9918-ED25-623EORCIDhttp://orcid.org0000-0002-1302-2570Faria, ÂngelaLopes, MárciaAfonso, SílviaHostingInstitutionOrganizationalBiblioteca Digital do IPBe-mailmailto:dspace@ipb.ptdspace@ipb.ptISSNIsPartOf0212-65672018-03-14T17:07:15Z20162016-01-01T00:00:00ZHandlehttp://hdl.handle.net/10198/16300http://purl.org/coar/access_right/c_abf2open accessErythematosus systemic lupusTherapy adherence313236 bytesother research producthttp://purl.org/coar/resource_type/c_c94fconference object2016http://creativecommons.org/licenses/by/4.0/http://purl.org/coar/access_right/c_abf2application/pdffulltexthttps://bibliotecadigital.ipb.pt/bitstreams/35f324ff-41cb-4adc-bf46-8ba81fda4492/download3rd World Congress of Health Research(Espec Cong 1):25-120483131Viseu, Portugal |
| spellingShingle | Erythematosus systemic lupus in Portugal: adherence and approach to medication therapy Pinto, Isabel C. Erythematosus systemic lupus Therapy adherence |
| subject.fl_str_mv | Erythematosus systemic lupus Therapy adherence |
| title | Erythematosus systemic lupus in Portugal: adherence and approach to medication therapy |
| title_full | Erythematosus systemic lupus in Portugal: adherence and approach to medication therapy |
| title_fullStr | Erythematosus systemic lupus in Portugal: adherence and approach to medication therapy |
| title_full_unstemmed | Erythematosus systemic lupus in Portugal: adherence and approach to medication therapy |
| title_short | Erythematosus systemic lupus in Portugal: adherence and approach to medication therapy |
| title_sort | Erythematosus systemic lupus in Portugal: adherence and approach to medication therapy |
| topic | Erythematosus systemic lupus Therapy adherence |
| topic_facet | Erythematosus systemic lupus Therapy adherence |
| url | http://hdl.handle.net/10198/16300 |
| visible | 1 |